chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: dizziness; shaking; tiredness; nauseated; shivering; initial headache; fever; This spontaneous case was reported by an other and describes the occurrence of DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated) and CHILLS (shivering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated), CHILLS (shivering), HEADACHE (initial headache) and PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), FATIGUE (tiredness) and HEADACHE (initial headache) had resolved and TREMOR (shaking), NAUSEA (nauseated), CHILLS (shivering) and PYREXIA (fever) outcome was unknown.            The concomitant medications information was not reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: dizziness; shaking; tiredness; nauseated; shivering; initial headache; fever; This spontaneous case was reported by an other and describes the occurrence of DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated) and CHILLS (shivering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated), CHILLS (shivering), HEADACHE (initial headache) and PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), FATIGUE (tiredness) and HEADACHE (initial headache) had resolved and TREMOR (shaking), NAUSEA (nauseated), CHILLS (shivering) and PYREXIA (fever) outcome was unknown.            The concomitant medications information was not reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Body Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Body Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Body Chills) and PYREXIA (Fever). At the time of the report, CHILLS (Body Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided   Reporter did not allow further contact
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included APIXABAN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Influenza, Neck pain, Pain in extremity, Sleep disorder
Clinical narrative: "flu" like symptoms; Soreness in upper arm that looked like it got "inflamed; pain radiated to back aream same side around scapula that feels like "hematoma"; pain is transient and moving to upper arm and lower neck; unable to sleep sue to pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA ("flu" like symptoms), PAIN IN EXTREMITY (Soreness in upper arm that looked like it got "inflamed), BACK PAIN (pain radiated to back aream same side around scapula that feels like "hematoma"), NECK PAIN (pain is transient and moving to upper arm and lower neck) and SLEEP DISORDER (unable to sleep sue to pain) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN, EZETIMIBE, METFORMIN HYDROCHLORIDE;SITAGLIPTIN, LISINOPRIL, METOPROLOL, INSULIN and ACETAZOLAMIDE for an unknown indication.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INFLUENZA ("flu" like symptoms), PAIN IN EXTREMITY (Soreness in upper arm that looked like it got "inflamed), BACK PAIN (pain radiated to back aream same side around scapula that feels like "hematoma"), NECK PAIN (pain is transient and moving to upper arm and lower neck) and SLEEP DISORDER (unable to sleep sue to pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, INFLUENZA ("flu" like symptoms), PAIN IN EXTREMITY (Soreness in upper arm that looked like it got "inflamed), BACK PAIN (pain radiated to back aream same side around scapula that feels like "hematoma"), NECK PAIN (pain is transient and moving to upper arm and lower neck) and SLEEP DISORDER (unable to sleep sue to pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included heat and ice pack.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Headache, Malaise
Clinical narrative: stomach is still in knots; hurting really bad; headache; muscle pain; joint pain; really bad chills; nausea; fever 80 something to 99.9; A spontaneous report was received from a healthcare professional concerning a 70-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache, muscle pain, joint pain, really bad chills, nausea, hurting really bad, fever 80 something to 99.9, stomach is still in knots, she was feeling a lot better on reporting day but woke up with real queasy stomach.  The patient's medical history included sinus allergy and has a current condition of hypertension. Losartan was concomitant medications reported by patient  On 12 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 07MZVA) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced headache, muscle pain (myalgia), joint pain (arthralgia), really bad chills, nausea, hurting really bad (malaise), fever 80 something to 99.9 (pyrexia), stomach is still in knots (abdominal pain upper). On 14 Feb 2021, she  woke up with really queasy stomach (nausea).  Treatment for events included tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: stomach is still in knots; hurting really bad; headache; muscle pain; joint pain; really bad chills; nausea; fever 80 something to 99.9; A spontaneous report was received from a healthcare professional concerning a 70-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache, muscle pain, joint pain, really bad chills, nausea, hurting really bad, fever 80 something to 99.9, stomach is still in knots, she was feeling a lot better on reporting day but woke up with real queasy stomach.  The patient's medical history included sinus allergy and has a current condition of hypertension. Losartan was concomitant medications reported by patient  On 12 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 07MZVA) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced headache, muscle pain (myalgia), joint pain (arthralgia), really bad chills, nausea, hurting really bad (malaise), fever 80 something to 99.9 (pyrexia), stomach is still in knots (abdominal pain upper). On 14 Feb 2021, she  woke up with really queasy stomach (nausea).  Treatment for events included tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Sore Arm; Headaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headaches) and CHILLS (chills) in a 77-year-old female elderly exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) , while the parent received the product for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy, Food allergy and Iodine allergy. Concomitant product exposures included ATORVASTATIN for an unknown indication.    On 27-Jan-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Feb-2021, the elderly was diagnosed with PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headaches) and CHILLS (chills). The elderly was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. On 12-Feb-2021, PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headaches) had resolved. At the time of the report, CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: Follow up received . Patient details , patient history, product batch number , event outcome, start date stop date new event are added
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Very itchy; Left arm sore for a few days,arm more tender; Developing rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE PAIN (Left arm sore for a few days,arm more tender) and VACCINATION SITE RASH (Developing rash) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE PAIN (Left arm sore for a few days,arm more tender) and VACCINATION SITE RASH (Developing rash). At the time of the report, VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE PAIN (Left arm sore for a few days,arm more tender) and VACCINATION SITE RASH (Developing rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Musculoskeletal pain, Pain in extremity, Reflux gastritis
Clinical narrative: Pain under last rib; Upper abdomen and breastbone very painful; Couldn't take a deep breath; Reflux; Sore arm; A Spontaneous case was received from consumer , concerning a female patient  of age 61, who received Moderna's COVID-19 vaccine experienced Pain in extremity/Sore arm, Chest pain/ Pain under last rib, Musculoskeletal pain/ Upper abdomen and breastbone very painful, Dyspnoea/ Couldn't take a deep breath, Reflux gastritis/ Reflux.  The patient's medical history was not provided. The Patient's concomitant medications were vitamins pills.  On  21Jan2021 , prior to the onset of events, the patient received his first of two planned doses of mRNA-1273 (Batch number : 043L20A) via intramuscular route for COVID-19 infection prophylaxis.  On 21Jan2021, the patient had a sore arm. On 21Jan2021, she immediately developed pain under the last ribcage (lasted from 22 to 23Jan) and then hours 19 to 24hs later the upper abdomen and center of chest became very painful. Didn't have difficulty breathing but was difficult to make a full expansion because of pain. After the 48hs everything except GI area had improved and started using omeprazole and Gaviscon.  The action taken in response to the events, Pain in extremity, Chest pain, Musculoskeletal pain, Dyspnoea, Reflux gastritis was unknown.  The outcome of the events, Pain in extremity, Chest pain, Musculoskeletal pain, Dyspnoea, Reflux gastritis was considered to be unknown.  The treatment medications reported to be taken by the patient were omeprazole and Gaviscon.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Vaccination site rash, Wheezing
Clinical narrative: Wheezing; Throat Pain; Rash on Injection site; A spontaneous report was received from a consumer concerning a 72-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash (injection site)/vaccination site rash, wheezing, throat pain./oropharyngeal pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031L20A) Intramuscularly for prophylaxis of COVID-19 infection.  On 7 Feb 2021, the patient experienced the event(s) rash (injection site), wheezing, throat pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash (injection site), wheezing, throat pain was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: A spontaneous report was received from a consumer concerning an unspecified age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red pigmentation on her injection site/vaccination site erythema and itchy/vaccination site pruritus.  The patient's medical history was not provided by the reporter. Concomitant product use was not provided by the reporter  On 28 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) via unknown route of administration for prophylaxis of COVID-19 infection.   On 05 Feb 2021, the patient experienced red pigmentation on her injection site and itchy but does not interrupt her. The second dose is scheduled on 25 Feb 2021.  Lab details were not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, red pigmentation on her injection site and itchy were unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Severe Arm Pain; Severe Itching; Severe Body Aches; 101.9F fever; Severe Headache; Nausea; Vomiting; Redness at injection site 6 cm in diameter; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever) and HEADACHE (Severe Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever), HEADACHE (Severe Headache), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE ERYTHEMA (Redness at injection site 6 cm in diameter). The patient was treated with HYDROCODONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever), HEADACHE (Severe Headache), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE ERYTHEMA (Redness at injection site 6 cm in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment also includes a Antibiotic   Reporter did not allow further contact
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vomiting
Clinical narrative: Severe Arm Pain; Severe Itching; Severe Body Aches; 101.9F fever; Severe Headache; Nausea; Vomiting; Redness at injection site 6 cm in diameter; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever) and HEADACHE (Severe Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever), HEADACHE (Severe Headache), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE ERYTHEMA (Redness at injection site 6 cm in diameter). The patient was treated with HYDROCODONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Severe Arm Pain), VACCINATION SITE PRURITUS (Severe Itching), MYALGIA (Severe Body Aches), PYREXIA (101.9F fever), HEADACHE (Severe Headache), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE ERYTHEMA (Redness at injection site 6 cm in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment also includes a Antibiotic   Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Body aches; A spontaneous report was received from a 22-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills and fever, body ache.   The patient's medical history, as provided by the reporter, included COVID-19 infection during mid-November and recovered by the end of November.  No concomitant medications were reported.   On 31 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 031L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On the evening of 31 Jan 2021, after receiving mRNA-1273, the patient felt "worse".  The patient experienced chills, fever, and body aches which lasted for 2 days.   Action taken with mRNA-1273 in response to the events was not reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swelling on left side of Face; A Spontaneous report was received from a Consumer concerning 78 years old, female patient who experienced swelling of face.  The patient's medical history was not reported.   No Concomitant medicines were reported. Lab details were unknown.  On 02 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 031L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On unspecified date, the patient experienced swelling of face. Treatment for the event included: Zyrtec, Benadryl, and Nasal Spray Action taken with mRNA-1273 in response to the events unknown. The outcome of the event was reported as Not Recovered / Not Recovered. Consent was given for follow up from Safety.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Depressed mood, Headache, Pyrexia, Swelling
Clinical narrative: down for the count; chills; fever; headache; swelling; A spontaneous report was received from a healthcare professional concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events down for the count, fever, chills, headache, swelling.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029K20A or 027K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the events down for the count. fever, chills, headache and swelling.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, down for the count, fever, chills, headache and swelling was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Sneezing
Clinical narrative: coughing; sneezing; This spontaneous case was reported by an other health care professional and describes the occurrence of COUGH (coughing) and SNEEZING (sneezing) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure (concomitant medicine) since an unknown date and Cholesterol (concomitant medication) since an unknown date.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (coughing) and SNEEZING (sneezing). At the time of the report, COUGH (coughing) and SNEEZING (sneezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication not reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Influenza, Nasal congestion, Oropharyngeal pain, Pain in extremity
Clinical narrative: Sore throat; Nasal congestion; Flu symptoms; Lot of pain in the arm; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Lot of pain in the arm), HYPERHIDROSIS (Sweating), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Nasal congestion) and INFLUENZA (Flu symptoms) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder since an unknown date.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Lot of pain in the arm) and HYPERHIDROSIS (Sweating). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Nasal congestion) and INFLUENZA (Flu symptoms). The patient was treated with IBUPROFEN at a dose of 200 mg; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Cold, at an unspecified dose and frequency. On 12-Feb-2021, PAIN IN EXTREMITY (Lot of pain in the arm) had resolved. At the time of the report, HYPERHIDROSIS (Sweating), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Nasal congestion) and INFLUENZA (Flu symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included AFib (She also has Afib).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported were blood thinner medication. No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Pain in extremity, Pyrexia, Throat tightness
Clinical narrative: Feels like dripping in back of throat; Running a fever of 103; sore arm; dry, intermittent cough; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), COUGH (dry, intermittent cough), THROAT TIGHTNESS (Feels like dripping in back of throat) and PYREXIA (Running a fever of 103) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and COUGH (dry, intermittent cough). On 02-Mar-2021, the patient experienced THROAT TIGHTNESS (Feels like dripping in back of throat) and PYREXIA (Running a fever of 103). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), COUGH (dry, intermittent cough), THROAT TIGHTNESS (Feels like dripping in back of throat) and PYREXIA (Running a fever of 103) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Pyrexia: 103 (High) Running a fever of 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: felt weak; muscle pain on both their legs,; Tired; very bad headache; chills; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (felt weak), FATIGUE (Tired), HEADACHE (very bad headache), CHILLS (chills) and MYALGIA (muscle pain on both their legs,) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Pelvic fracture in September 2020 and Breast cancer (breast cancer from October 2020 to January 2021.) since October 2020. Concurrent medical conditions included Allergy (patient mentions they are allergic to several things). Concomitant products included POTASSIUM, PROPAFENONE HYDROCHLORIDE, TOPIRAMATE, DIAZEPAM, FAMOTIDINE, DIVALPROEX SODIUM and SOLIFENACIN SUCCINATE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Tired), HEADACHE (very bad headache) and CHILLS (chills). On 27-Feb-2021, the patient experienced ASTHENIA (felt weak) and MYALGIA (muscle pain on both their legs,). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and TRAMADOL for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (felt weak), FATIGUE (Tired), HEADACHE (very bad headache), CHILLS (chills) and MYALGIA (muscle pain on both their legs,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Ultrasound scan, Vaccination complication, Vaccination site swelling
Clinical narrative: uncomfortable feeling; have to put hand on hips; elongated inflammation; swelled up under left arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (uncomfortable feeling; have to put hand on hips), VACCINATION COMPLICATION (elongated inflammation) and VACCINATION SITE SWELLING (swelled up under left arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included IBUPROFEN from 08-Feb-2021 to an unknown date for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelled up under left arm). On 10-Feb-2021, the patient experienced LIMB DISCOMFORT (uncomfortable feeling; have to put hand on hips) and VACCINATION COMPLICATION (elongated inflammation). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (uncomfortable feeling; have to put hand on hips), VACCINATION COMPLICATION (elongated inflammation) and VACCINATION SITE SWELLING (swelled up under left arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Ultrasound scan: Patient described findings as elongated inflammation, almost snake-like and it was an inch in diameter..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included warm compress.   Most recent FOLLOW-UP information incorporated above includes: On 08-Aug-2021: Follow up document included patient's age
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at site of injection) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at site of injection). On 27-Jan-2021, VACCINATION SITE PAIN (Soreness at site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD21-043651 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Fatigue, Vaccination site pain
Clinical narrative: spike in temperature to 100 F; chills; fatigue; soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (spike in temperature to 100 F), VACCINATION SITE PAIN (soreness at site of injection), CHILLS (chills) and FATIGUE (fatigue) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at site of injection). On 02-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (spike in temperature to 100 F), CHILLS (chills) and FATIGUE (fatigue). On 02-Mar-2021, BODY TEMPERATURE INCREASED (spike in temperature to 100 F) and VACCINATION SITE PAIN (soreness at site of injection) had resolved. On 03-Mar-2021, CHILLS (chills) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100 (Inconclusive) Body temperature increased..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.     This case was linked to MOD21-043648 (Patient Link).
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Injection site pain, Pyrexia
Clinical narrative: dizziness; fever; chills; pain at injection; ringing in ear (L) and (R); weakness; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ear (L) and (R)), ASTHENIA (weakness), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis ((Humira) history-medication stopped 3 weeks prior and 1 week after Moderna injections) since an unknown date. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced TINNITUS (ringing in ear (L) and (R)), ASTHENIA (weakness), PYREXIA (fever), CHILLS (chills) and INJECTION SITE PAIN (pain at injection). On 11-Feb-2021, the patient experienced DIZZINESS (dizziness). On 11-Feb-2021, ASTHENIA (weakness), PYREXIA (fever), CHILLS (chills) and INJECTION SITE PAIN (pain at injection) outcome was unknown. At the time of the report, TINNITUS (ringing in ear (L) and (R)) and DIZZINESS (dizziness) outcome was unknown.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: dizziness; fever; chills; pain at injection; ringing in ear (L) and (R); weakness; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ear (L) and (R)), ASTHENIA (weakness), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis ((Humira) history-medication stopped 3 weeks prior and 1 week after Moderna injections) since an unknown date. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced TINNITUS (ringing in ear (L) and (R)), ASTHENIA (weakness), PYREXIA (fever), CHILLS (chills) and INJECTION SITE PAIN (pain at injection). On 11-Feb-2021, the patient experienced DIZZINESS (dizziness). On 11-Feb-2021, ASTHENIA (weakness), PYREXIA (fever), CHILLS (chills) and INJECTION SITE PAIN (pain at injection) outcome was unknown. At the time of the report, TINNITUS (ringing in ear (L) and (R)) and DIZZINESS (dizziness) outcome was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nervousness, Pain in extremity, Pyrexia
Clinical narrative: sore arm; red circle and rash at injection site; red circle and rash at injection site; It is itching terribly; severe headache; vision not really good; feels shaky; temperature of 101; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly) and HEADACHE (severe headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly), HEADACHE (severe headache), VISUAL IMPAIRMENT (vision not really good), NERVOUSNESS (feels shaky) and PYREXIA (temperature of 101). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly), HEADACHE (severe headache), VISUAL IMPAIRMENT (vision not really good), NERVOUSNESS (feels shaky) and PYREXIA (temperature of 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Visual impairment
Clinical narrative: sore arm; red circle and rash at injection site; red circle and rash at injection site; It is itching terribly; severe headache; vision not really good; feels shaky; temperature of 101; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly) and HEADACHE (severe headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly), HEADACHE (severe headache), VISUAL IMPAIRMENT (vision not really good), NERVOUSNESS (feels shaky) and PYREXIA (temperature of 101). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (red circle and rash at injection site), VACCINATION SITE RASH (red circle and rash at injection site), VACCINATION SITE PRURITUS (It is itching terribly), HEADACHE (severe headache), VISUAL IMPAIRMENT (vision not really good), NERVOUSNESS (feels shaky) and PYREXIA (temperature of 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypertension, Injection site pain, Vertigo
Clinical narrative: Dizziness; Head spinning feeling; Blood pressure "skyrocketed"; Sore arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore arm at injection site), VERTIGO (Head spinning feeling), HYPERTENSION (Blood pressure "skyrocketed") and DIZZINESS (Dizziness) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METOPROLOL, CLOPIDOGREL BISULFATE (PLAVIX), ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN CALCIUM (LIPITOR) and LOSARTAN for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore arm at injection site). On 19-Feb-2021, the patient experienced VERTIGO (Head spinning feeling) and HYPERTENSION (Blood pressure "skyrocketed"). On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, INJECTION SITE PAIN (Sore arm at injection site), VERTIGO (Head spinning feeling) and HYPERTENSION (Blood pressure "skyrocketed") outcome was unknown and DIZZINESS (Dizziness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included Cataract eye drops. No treatment medications were provided by reporter.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Influenza like illness
Clinical narrative: Flu like symptoms; Pain in her arms; Muscle pain; Joint pain; Headache; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Flu like symptoms; Pain in her arms; Muscle pain; Joint pain; Headache; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.